Amantanium bromide

Description:
Amantadine is a prodrug that is hydrolyzed in vivo to form the active compound, amantadine triphosphate. It has antiviral activity against influenza virus and other RNA viruses. Amantadine is used to treat influenza A and B infections, as well as symptoms of influenza-like illness. This drug was approved by the FDA in 1967 and has been used as an alternative to neuraminidase inhibitors such as oseltamivir or zanamivir. Amantadine inhibits the release of neurotransmitters from nerve endings and may have some efficacy in treating neurodegenerative diseases such as Parkinson’s disease, Huntington’s disease, or Alzheimer’s disease. Amantadine requires a water vapor to be effective because it is poorly soluble in water.